Navigating resistance to ALK inhibitors in the Lorlatinib Era: a comprehensive perspective on NSCLC.
Article in Expert Review of Anticancer Therapy (April 2024)
The most recent citing publications are shown below. View all 435 publications that cite this research output on Dimensions.
Article in Expert Review of Anticancer Therapy (April 2024)
Article in European Journal of Medicinal Chemistry Reports (April 2024)
Article in npj Precision Oncology (March 2024)